Approved Hospital Formulary
Add Formweb to your mobile device
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Pharmacy News:
12/22/21 je Ceftolozane-tazobactam Backorder Update
December 27, 2021
From: "Jonathan Edwards" <jonathan.edwards@hhsys.org>
To: "Pharmacists" <grp_allpharm@hhsys.org>
Sent: Wednesday, December 22, 2021 10:10:16 AM
Subject: Fwd: Ceftolozane-tazobactam Backorder Update
Pharmacists,
Ceftolozane-tazobactam (ZERBAXA) is no longer on backorder. We have a total of 20 vials in stock. I will be notifying the ID physicians later today that they can begin ordering this medication again.
Just as a reminder, this antibiotic is classified as formulary restricted to ID for documented MDR Pseudomonas when other options are not appropriate.
Please let me know if you have any questions.